Landscapes / Companies
Apollo Therapeutics Ltd not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
1 in Phase 1
Drugs
3
in active trials · 4 in all
Trials
3 active
6 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | 30 Aug 2027Phase 2 trial completes | |||
| Next date | 30 Aug 2027 · Phase 2 trial completes | ||||
| Also tested for | Pulmonary Arterial Hypertension | ||||
| Open drug page | |||||
Monoclonal antibody |
Phase 2 | 31 Oct 2027Phase 2 trial completes | |||
| How it works | An antibody | ||||
| Next date | 31 Oct 2027 · Phase 2 trial completes | ||||
| Also tested for | Atopic Dermatitis, Atopic and 6 more | ||||
| Open drug page | |||||
— |
Phase 1 | Jul 2027Phase 1 trial completes | |||
| Next date | Jul 2027 · Phase 1 trial completes | ||||
| Also tested for | Acute Myeloid Leukemia Refractory, Myelodysplastic Syndrome Acute Myeloid Leukemia and 4 more | ||||
| Open drug page | |||||
About
- No active trial
- APL-5125
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021